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ABSTRACT
Metastases in the liver frequently grow as scattered tumor nodules which neither can be removed by
surgical resection nor focally ablated. Previously, we have proposed a novel technique based on irreversible
electroporation which may be able to simultaneously treat all nodules in the liver while sparing healthy
tissue. The proposed technique requires increasing the electrical conductivity of healthy liver by injecting
a hypersaline solution through the portal vein. Aiming to assess the capability of increasing the global
conductivity of the liver by means of hypersaline fluids, here it is presented a mathematical model which
estimates the NaCl distribution within the liver and the resulting conductivity change. The model fuses well-
established compartmental pharmacokinetic models of the organ with saline injection models employed for
resuscitation treatments and it considers changes in sinusoidal blood viscosity due to the hypertonicity of the
solution. Here it is also described a pilot experimental study in pigs in which different volumes of NaCl 20%
(from 100 to 200 ml) were injected through the portal vein at different flow rates (from 53 to 171 ml/min).
The in vivo conductivity results fit those obtained by the model, both quantitatively and qualitatively, being
able to predict the maximum conductivity with a 14.6% average relative error. The maximum conductivity
value was 0.44 S/m which corresponds to increasing four times the mean basal conductivity (0.11 S/m). The
results suggest that the presented model is well suited for predicting on liver conductivity changes during
hypertonic saline injection.




The liver has a distinctive blood supply in which blood comes from two different pathways. About
70% of blood comes from the portal vein whereas the remaining supply comes from the hepatic
artery [1]. Both afferent vessels branch into venules and arterioles, eventually draining into the
sinusoids, which are capillaries with fenestrations along their endothelial wall. These fenestrations
allow the passage of small particles from the sinusoids to the hepatocytes across the interstitial space
that surrounds the hepatocytes. Blood leaves the liver lobules through the central veins and it finally
drains into the cava vein [2].
The dual blood supply of the liver and the presence of fenestrations in the sinusoids increase the
likelihood of metastatic deposits in the liver [3]. Almost any primary cancer can spread to the liver
and, when that happens, tumors commonly grow as scattered nodules [4]. About half of the patients
with colorectal cancer develop hepatic metastases and less than 30% of those patients are suitable
for surgical resection [5], thus portending a poor prognosis.
In addition to surgical resection, the current medical armamentarium includes a set of loco
regional therapies for ablating malignant liver tissues which can be applied to patients who are
non-surgical candidates because of comorbidity or extensive disease. These focal liver ablation
techniques include percutaneous ethanol injection, radiofrequency ablation, high-intensity focused
ultrasound, microwave ablation and cryosurgery [6]. These techniques, however, because of their
focal nature, are not adequate for patients in which the number of scattered nodules is large (>3)
[7]. As an alternative, we have recently proposed a technique based on irreversible electroporation
which may be able to simultaneously treat all nodules in the liver while sparing healthy liver tissue
[8].
Electroporation is the phenomenon in which cell membrane permeability is increased by exposing
the cell to high electric field pulses [9]. If the pulses are very intense, the permeabilization causes
the cells to loss their homeostasis and die. This process is known as irreversible electroporation
(IRE). IRE was proposed a few years ago as a focal ablation technique [10] and it has been clinically
assayed [11]. Since electroporation does not involve thermal or chemical damage to the extracellular
matrix, it allows to retain the structural integrity of the blood vessels and the nerves [12]. This fact
allows treatment of tumors located close to critical structures which are unsuitable to be treated with
other focal ablation techniques based on high-temperature. However, while IRE shows promising
results treating non-resectable tumors [13], as a focal therapy, it is only recommended for treatment
of less than three nodules with relatively small dimensions (< 5 cm) [7].
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Interestingly, while healthy hepatocytes receive both arterial and venous blood, tumor nodules
have a disorganized vascular structure, lacking sinusoids, which implies they are almost only
supplied with arterial blood coming from the hepatic artery [14]. In view of the foregoing, we
propose to inject a hypertonic saline solution with high electrical conductivity through the portal
vein so that the overall conductivity of the healthy tissue increases whereas the conductivity in the
tumor nodules is kept constant. Then, by applying high voltage pulses across two large electrode
plates sandwiching the liver, a significantly larger field would be caused in the tumors than in the
rest of the tissue, as described in the previous theoretical study [8]. In this way, it would be possible
to cause electroporation of the tumor nodules while avoiding the effect in healthy parenchyma. This
approach would have some major advantages with respect to the focal ablation techniques used in
non-resectable tumor nodules. Namely, it would not be required to identify the exact position of the
tumor nodules during the intervention and it would be possible to treat several tumor nodules at the
same time making unnecessary to address them individually.
Prior to further development of the proposed technique, it is required to assess the capability to
increase the electrical conductivity of the liver. We deem that the proposed liver electroporation
technique will require increasing healthy liver conductivity by a minimum factor of 3 [8]. Here,
in order to elucidate the expected behavior of conductivity during the procedure, a comprehensive
mathematical model has been developed to predict both the temporal distribution of solute within
the liver and the resulting electrical conductivity of the tissue.
Several studies have performed mathematical models of the liver to computationally assess the
pharmacokinetic behavior of a defined drug or chemical agent [15, 16, 17, 18]. These studies usually
employed the so called physiologically based pharmacokinetic (PBPK) models which represent the
anatomical and physiological structure of the organ by using interconnected fluidic compartments.
However, as the employed drug concentrations are commonly low, these models neglected osmotic
effects which are relevant in our case. On the other hand, hypertonic saline infusions have been
used in fluid resuscitation for hemorrhagic patients [19] and some mathematical models have
been developed aiming to determine the distribution at systemic level [20]. Here we fuse both
modeling approaches in a novel model using the transport functions employed in the PBPK models
in combination with the osmotic formulation from resuscitation models.
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2. MATERIALS AND METHODS
2.1. Mathematical Model
2.1.1. Liver Conductivity The electrical conductivity of a tissue at low frequency mainly depends
on the extracellular solution conductivity and the structural morphology [21, 22] . Among the
chemical species that constitute the extracellular body fluids, sodium and chlorine are the main
contributors to the electrical conductivity. Consequently, here it was assumed that only sodium and
chlorine ions contribute to the conductivity of the extracellular plasma [23].
By injecting a hypertonic NaCl solution into the bloodstream, the NaCl concentration of the
plasma is altered. To determine the conductivity of plasma (σp) at different NaCl concentrations
(Cp), experimental data reported on NaCl solutions [24] was fitted with an exponential function
(R2 > 0.99):
The electrical conductivity of a tissue at low frequency mainly depends on the extracellular
solution conductivity and the structural morphology [21, 22] . Among the chemical species that
constitute the extracellular body fluids, sodium and chlorine are the main contributors to the
electrical conductivity. Consequently, here it was assumed that only sodium and chlorine ions
contribute to the conductivity of the extracellular plasma [23].
By injecting a hypertonic NaCl solution into the bloodstream, the NaCl concentration of the
plasma is altered. To determine the conductivity of plasma (σp) at different NaCl concentrations













The reported experimental data were obtained at 20◦C, therefore, an additional term was added
for being able to assess the conductivity at body temperature (T = 37◦C) taking into account the
exponential conductivity grow of 2◦C experienced by ionic solutions [25].
Physiological blood conductivity (about 0.65 S/m) differs substantially from that of the plasma
(about 1.57 S/m). This difference is caused by the presence of red blood cells (RBCs) which, at low
frequencies, can be considered as non-conductive elements [26]. Archies law [27] is extensively
used in geology to assess the equivalent electric conductivity of composite materials [28]. Similarly,
Archies law has also been employed to determine the electrical conductivity of biological tissues
[26]. For a material composed by an aqueous medium with conductivity σsolv and non-conductive
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particles occupying a volume fraction (φp), the effective conductivity of the material (σeff ) can be
expressed as:
σeff = σsolv(1 − φp)m (2)
where m is a factor dependent on the shape of particles. The blood is mainly a suspension
of non conductive RBCs in solvent (plasma). Therefore, according to Equation (2), the electrical
conductivity of blood in sinusoids (σs) depends on its plasma conductivity (σp,s) and the hematocrit
value (hs). According to the shape of erythrocytes, a value m = 1.46 has been reported [26], and
thus:
σs = σp,s(1 − hs)1.46 (3)
The same can be employed to compute the conductivity of the whole liver parenchyma. Using
Equation (2) for the specific case of the liver parenchyma, the clusters of hepatic cells can be
considered as the non-conductive particles which occupy a certain volume (Vc,hp) of the parenchyma
volume (VP ). According to the cluster shape, the conductivity of the liver (σL) can be approximated
using a shape factor value (m) of 1.67 [26]:




In this case the solvent conductivity (σsi) is assumed to be a mixture between the conductivities
of blood at sinusoids (σs) and the plasma at the interstitium (σp,hp). For a material composed by
n compounds with a specific electrical conductivity (σj) and volume fraction (φj), and randomly








Using Equation (5) it is possible to compute the effective conductivity of the composite material










2.1.2. Compartmental Model A mathematical model was developed aiming at assessing both
the fluid and solute movement within the liver. This model provides the parameters required to
estimate the electrical conductivity of the liver parenchyma according to the formulation previously
described.
Based on already reported models [15, 16, 30], a compartment model was implemented (see
Figure 1). The model has four macroscopic compartments. Two of them represent the intrahepatic
portal and arterial vasculature and the other two represent the hepatic parenchyma which consists of
































Figure 1. Representation of the compartmental model employed to simulate NaCl concentration. Composed
by 8 sub-compartments, each one of them characterized by a volume Vx,y and an equivalent NaCl
concentration Cx,y where x denotes the extracellular (p) or intracellular (c) liquid and y denotes the
macroscopic compartment (pv: Portal Vein, ha: Hepatic Artery, s: Sinusoids or hp: Hepatocellular Plates).
Black arrows represent blood flow (movement of plasma liquid and RBC) while grey arrows symbolize
liquid flow.
The model describes three supplying flows: one of these symbolizes the hypersaline infusion
and the other two represent the normal incoming blood flows. The hypersaline solution flow (Qhs),
directly contributing to extracellular liquid in the portal vasculature, is modeled as a square pulse
with a magnitude according to the flow employed during the experiments and with the corresponding
constant concentration (Chs). Moreover, the blood supplies are characterized by their constant
physiological flows (Qpv and Qha), concentration (Cphys) and hematocrit (hphys). Eventually blood
exits from the sinusoids through the hepatic vein (Qhv = Qhs +Qpv +Qha).
In the sinusoidal macroscopic compartment, plasma with concentration Cp,s, crosses, through the
capillary wall, into the interstitial space in the hepatocellular plates at filtration flow rate Qf and, at
Qr flow rate, interstitial fluid with concentration Cp,hp is reabsorbed by the sinusoids.
The filtration and reabsorption flows (Qf and Qr) between the sinusoids and the interstitial space
of the hepatocellular plates are commonly included in models as constant parameters. Here, in
contrast, are considered to be pressure dependent. It is well known that filtration flow in sinusoids
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is determined by the capillary filtration coefficient (Kf ) multiplied by the hydrostatic pressure
difference between capillary and interstitium [31]. At the beginning of the sinusoid, closer form
portal tract, sinusoidal pressure (Ps) is higher than the interstitial one (Pi) producing a filtration
flow from the sinusoid to the interstitium.
Qf (t) = Kf (Ps(t) − Pi(t)) (7)
Moreover, closer to the hepatic vein, the capillary pressure (Phv) is lower than interstitial
producing the reabsorption flow.
Qr(t) = Kf (Pi(t) − Phv) (8)
According to Eqs. (7), (8) and the mass conservation, the filtration flow must be the same than
the reabsorption flow, and this results in:
Qf (t) = Qr(t) = Kf (Ps(t) − Phv) (9)
For a defined capillary geometry and a constant blood flow, the resulting pressure at the entrance
of the capillaries depends proportionally on fluid viscosity [32]. However, an acute pressure increase
has been observed in the microvasculature when HS is injected into the blood stream [33]. This
increase of pressure is attributed to the HS effect on RBCs [34].
It has been also reported a dynamic viscosity almost linearly dependent with osmolality [35].
Linearizing this reported data (R2 > 0.99) at shear rate stress similar to the sinusoidal one (230








Although the increase of viscosity affects the whole liver vasculature, the apparent viscosity in
large vasculature (i.e. hepatic artery, portal vein and hepatic veins) does not increase as much as
in the sinusoids [35]. Therefore, here it is only considered the viscosity dependence effect over the
sinusoids.
This pressure can be estimated according to the hepatic vein vasculature pressure (Phv,phys), the
sinusoidal flow resistance (Rs,phys) and the viscosity (µphys) at physiological state, and along with
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The amount of solute used in pharmacological studies is usually low. Therefore, the commonly
employed PBPK models of the liver do not consider osmotic flow between compartments. However,
as the HS osmolarity highly differs from the physiological one, the osmotic equilibrium plays
an important role in the case modeled here. Thus, each one of the macroscopic compartments is
divided into two sub-compartments, one of them representing the extracellular liquid and the other
representing the liquid confined within the cells. A difference in osmolarity between plasma and
cellular sub-compartments leads to the water movement across the cell membrane (Qc) trying to
reach equilibrium. According to mathematical models used in the resuscitation field [20], the flow
of water from cells to plasma (Qc) depends on its membrane hydraulic conductivity (Lc), the cells
plasma surface area (Sc) - considered as constant - and the osmotic pressure difference between
both compartments (∆Π).
Qc(t) = LcSc∆Π (13)
Although the ions within the cell differ from those found in the extracellular space, the osmolarity
of both compartments is kept at the same value (308 mol/m3). Therefore, for the sake of simplicity,
as no exchange of solutes is assumed across the cell membrane, here the intracellular concentration
is defined as a NaCl concentration although, in reality, the intracellular content differs from a NaCl
solution. In other words, Cc indicates the concentration of NaCl that would produce the same
osmolarity within the cell. Cc does not represent the actual concentration of intracellular species
but it is proportional to it. Such simplification is just used for computing the osmotic pressure.
∆Π = RT (2Cp − 2Cc) (14)
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The osmotic pressure difference (∆Π) between two compartments is defined in Equation (14) by
their osmolarity (two times the concentration in case of a NaCl solution), the temperature (T = 310
K) and the gas constant (R = 0.06236 m3·mmHg/(K·mol)).
The model computes the time course of the concentration in each sub-compartment. The liquid
and solute exchanges are formalized by the physiological parameters shown in Table I and by
the following differential equations derived from the conservation of mass. Runge-Kutta method
was employed (MatLab R2014b, MathWorks, Natick, MA, USA) to solve the resulting system of
equations:
Table I. Physiological parameters employed in the model.
Symbol Description Value Source
Cphys Physiological NaCl concentration 154 mol/m3 [20]
Qpv Flux of blood through portal vein 24.0 ml/(min·kg) [36]
Qha Flux of blood through hepatic artery 8.4 ml/(min·kg) [36]
Kf Filtration coefficient of sinusoids wall 3 ml/(min·mmHg·kg) [31]
Ps,phys Physiological pressure at sinusoids 4.4 mmHg [37]
Phv,phys Physiological pressure at the hepatic vein 1.5 mmHg [37]
hphys Physiological hematocrit 45% [38]
VL Liver volume 30.3 ml/kg [36]
Vpv Portal vasculature volume 13.3×10−2 VL See Appendix
Vha Hepatic artery vasculature volume 4.6×10−2 VL See Appendix
Vhv Hepatic vein vasculature volume 16.2×10−2 VL See Appendix
VP Parenchyma volume 65.9×10−2 VL VL − Vpv − Vha − Vhv
Vc,hp Hepatocyte volume at physiological state 77.8×10−2 VP [39]
Vp,hp Interstitial volume at physiological state 4.9×10−2 VP [39]
Vs Sinusoidal volume 10.6×10−2 VP [39]
ρL Liver density 1070 kg/m3 [40]
Sc,pv Portal RBC membrane surface 859.5 cm2/ml VL [20]hphys Vpv
Lc,pv Membrane hydraulic conductivity 7.2×10−7 ml/(min·mmHg·cm2) [20]
Sc,ha Arterial RBC membrane surface 297.3 cm2/ml VL [20]hphys Vha
Lc,ha Membrane hydraulic conductivity 7.2×10−7 ml/(min·mmHg·cm2) [20]
Sc,s RBC membrane surface in sinusoids 451.5 cm2/ml VL [20]hphys Vs
Lc,s Membrane hydraulic conductivity 7.2×10−7 ml/(min·mmHg·cm2) [20]
Sc,hp Hepatocyte-interstitium surface 337.9 cm2/ml VL See Appendix




= ChsQhs(t) + CphysQpv(1 − hphys)


















= Cp,pv(t)(Qhs +Qpv)(1 − hpv) + Cp,ha(t)Qha(1 − hha(t))





= Cc,pv(Qhs(t) +Qpv)hpv(t) + Cc,ha(t)Qhahha(t)
















2.2. In Vivo Pilot Study
2.2.1. Animal Model All actions in this study were performed in accordance with the protocol
approved by the Ethical Commission of the Universitat Autònoma de Barcelona (authorization
number CEEAH 2205/ DMAH 7633) following the European Directive 2010/63/EU on the
protection of animals used for scientific purposes. A total of 5 procedures – one in each animal
– were performed under general anesthesia on Landrace pigs (mean weight 57 kg).
2.2.2. Procedure Preoperative care and anesthesia were provided by fully trained veterinary staff.
The anesthetic induction phase was performed with propofol (4 mg/kg I.V.) and maintained with
isoflurane from 1.5 to 2% and oxygen 100% mixture once the animal was endotracheally intubated.
Oxygen saturation, arterial blood pressure, heart rate and capnography were monitored using a
multiparametric monitor.
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By midline laparotomy, after dissection of the hepatoduodenal ligament, extrahepatic portal vein
catheterization was performed in order to deliver either a hypersaline solution (NaCl at 20%) or
an isotonic solution (NaCl 0.9%) in the control case. After exposure, the portal vein was dissected
free and cannulated through a purse-string suture placed just cranial (approximately 1 cm) to the
entry point of the cranial pancreaticoduodenal vein with a simple silastic catheter (dropper tube).
The catheter was advanced cranial to a point just proximal to the main portal division and secured
in place via the purse-string suture and a single stay suture. The solution volume employed in the
procedures was injected by using a dropper while infusion durations were measured with a stop
watch. Aiming to explore the conductivity dependence in both the amount of solution injected and
the flow rate, different values were employed (see Table II).
Table II. Injection parameters employed in animal experiments
Animal NaCl (%) Volume (ml) Duration (s) Flow (ml/min)
#1 20 100 113 53
#2 20 100 52 115
#3 20 120 60 120
#4 20 200 70 171
#5 0.9 500 120 250
Although the planned therapeutic technique involves hepatic vascular isolation, such strategy was
not employed during this pilot study aiming to simplify the experimental setup. However, since rapid
infusion of a high amount of HS could cause severe damage to the animal and a high disturbance of
the normal blood flow [41] which could distort the study, it was decided to adopt a relatively simple
approach to prevent those consequences. Specifically, in order to minimize the possible ionic and
osmotic imbalance at systemic level caused by the HS, as recommended to manage hypernatremia
[42], distilled water was simultaneously injected at the cava vein. Using an additional catheter
with the same cannulation technique immediately cranial to entry point of the right renal vein
and advanced cranial two centimeters. The amount of injected water was ten times the hypersaline
volume in order to restore the NaCl concentration in the systemic blood.
2.2.3. Conductivity Measurement It is possible to measure the impedance of a living tissue portion
by inducing a known current through a pair of electrodes while measuring the resulting voltage
drop across them. In the presented study, the electrode setup consisted of two printed circuit boards
(PCBs) including a circular gold coated electrode (20 mm diameter). The PCBs were mounted on a
pincer clip so that the electrodes were securely placed at opposite sides of a hepatic lobule forming
a fixed geometry. The electrodes were placed at a distal section of the lobule to avoid the potential
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influence of large intrahepatic blood vasculature. Electrical impedance was measured at a rate of
five sweeps per second. The spectrogram consisted of six frequencies from 10 to 100 kHz. The
excitation signal was a sinusoidal signal with 1 V amplitude applied to the tissue through a 2 kΩ
resistor in order to limit the peak current to a maximum of 500 µA. Both the injected current and the
voltage drop over the tissue were simultaneously collected to compute the real and imaginary parts
of the impedance using a data acquisition board (NI USB-6212, National Instruments, Austin, TX,
USA) controlled by a virtual instrument (Labview 8.1, National Instruments, Austin, TX, USA).
The Cole model for bioimpedance can be employed to characterize the measured impedance (Z(f))
spectrogram with only four parameters: the hypothetical resistance at infinite (R∞) and zero (R0)
frequencies, the characteristic time constant τ and the dimensionless parameter α [43].




This equation was employed here to determine the hypothetical impedance magnitude at 0
Hz automatically fitting the equation (MatLab R2014b, MathWorks, Natick, MA, USA) to the
experimental data by minimizing the least squares error.
Once the impedance at 0 Hz was obtained in Equation (25), the conductivity at this frequency
(σ0) was calculated according to the geometric cell constant (K) of the measurement system as






According to the described formulation and the parameters of the Table I, the physiological electrical
conductivities at 37◦C of the plasma, blood and liver are 2.03 S/m, 0.85 S/m and 0.09 S/m
respectively.
Figure 2(a) shows the estimated evolution of the liver conductivity over the time. The simulation
results show a fast increase at the beginning of the infusion mainly due to the presence of high
conductivity medium in sinusoids (Figure 2(b)). Following that, the contribution of sinusoidal
medium remains constant while the interstitial contribution - due to the filtration process and
hepatocyte shrink - keeps growing until HS injection stops (Figure 2(c)). At this point, the rapid
decrease in liver conductivity can be attributed to the replacement of the high conductivity sinusoidal
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content by systemic blood. Meanwhile, the high conductivity plasma at the interstitial space is
arrested for a longer period of time, producing a remaining conductivity offset which requires longer










































































Figure 2. Temporal evolution of the computed electrical conductivity. Assessment of conductivity of the
liver (a), the sinusoidal blood (b) and the interstitial liquid (c). Plots correspond with an injection of 2 ml/kg
of 20% NaCl at 2 ml/(min·kg).
For an injected saline concentration of 20%, the model has two independent input parameters
corresponding to the flow rate and the total amount of solution introduced. The effect of each of
those inputs over the temporal evolution of the conductivity is shown in Figure 3. It can be observed
that the maximum electrical conductivity achieved at the end of the HS injection highly depends on
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Figure 3. Effect of flow rate and volume of injected saline on the temporal evolution of electrical conductivity
in the liver. Plots of (a) correspond with a fixed volume of 2 ml/kg of 20% NaCl, while plots in (b) correspond
with a constant flow rate of 2 ml/(min·kg).
About the in vivo pilot study, it is important to note that only the electrical conductivity of the liver
can be measured with the employed setup. The baseline electrical conductivity of the liver was very
similar in all the animals (0.11 ± 0.02 S/m). As observed in computer simulations, conductivity
progress always peaked just at the end of the injection. The maximum peak value was 0.44 S/m
(animal #4) and corresponded with an injection of 3.8 ml/kg at 3.3 ml/(min·kg) (Figure 4(a)).
Injection of a highly concentrated NaCl solution through portal vein produced a rapid increase of
conductivity with time until the injection stops. At this point, a portion of the achieved conductivity
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increase slowly receded exponentially with time. However, the liver conductivity remained at a
higher value than the basal one. In the control animal (animal #5), in which physiological saline
solution (NaCl 0.9%) was injected, the conductivity of the liver did not show any variation,



















































Figure 4. Temporal evolution of liver conductivity from simulations and experiments. (a): temporal evolution
in the case of an injection of 3.8 ml/kg (20% NaCl) at a flow rate of 3.3 ml/(min·kg). (b): temporal evolution
in case of injecting physiological saline solution (0.9% NaCl) which served as a control test.
Assessing with the model the resulting conductivity peak for a set of volumes and flows
combinations, it is possible to obtain tridimensional representation of the peak conductivity value
within a range of flow rates and volumes (Figure 5). Those values can be compared to the ones
obtained during the in vivo pilot study in order to assess the goodness of fit of the proposed model
in terms of relative error (Table III).























#1 2.2 1.2 0.091 0.206 0.124 0.210 26.6 1.7
#2 1.9 2.2 0.091 0.266 0.109 0.178 16.5 49.7
#3 2.6 2.6 0.091 0.304 0.137 0.295 33.8 3.2
#4 3.8 3.3 0.091 0.373 0.093 0.444 2.5 15.8
#5 0.0* 2.7 0.091 0.096 0.089 0.094 2.0 2.6
* 5.5 ml/kg 0.9% NaCl
4. DISCUSSION
In this study, a mathematical model was developed aiming to assess the electrical conductivity of the
liver once hypertonic saline solution is introduced through portal vasculature. Our main purpose was
to formulate a mathematical model useful to continue with the development of a novel multi-nodule

































Injected Volume of NaCl at 20% (ml/kg)
Figure 5. Dependence of conductivity peak on volume and flow of injected saline (20% NaCl). The surface
represents the simulated values from the proposed mathematical model, while circles represent the five
experimental results from the in vivo model. Gray lines denote the absolute error value between the values
predicted by the model and those experimentally observed.
Hypertonic saline solution has been extensively used in resuscitation of patients with traumatic
brain injury [44]. Using 7.2% NaCl intravenously injected, it has been reported a safety dosage of
5 ml/kg of body weight without inducing hypernatremia [45]. Accordingly to this safety value,
the maximum dosage at 20% NaCl would be 1.8 ml/kg. This amount is slightly below the
maximum doses tried and proposed here for significantly increasing liver conductivity. Therefore,
some sort of countermeasure is required for safety in order to avoid severe pathophysiological
effects, such as hyperchloremic acidosis or dilated coagulopathy [46]. For the presented pilot study
parallel downstream administration of distilled water was a feasible and effective countermeasure
to avoid acute dysfunctions at systemic level that could distort our study. However, the proposed
electroporation technique should include a sort of liver isolation similar to the employed in the
isolated hepatic perfusion (IHP) therapies [47]. That is, we anticipate extracting the hypertonic
solution as it leaves the liver.
Besides systemic effects, another source of concern would be the potential tissue damage
produced on the liver tissue itself due to the hypersaline injection. Nevertheless, according to
literature, a direct intratisular injection of hypersaline solution at very high dosage (36.5% NaCl)
is required to produce small tissue damage [48]. And according to the presented model, at the
maximum dosage employed during the in vivo experiments, interstitial concentration hardly reaches
a concentration of 1% NaCl. Therefore hepatocellular damage due to portal injection of the
hypersaline solution is not anticipated.
The developed model accounts for the increased blood viscosity in the sinusoids due to the high
osmolarity of the HS. Such increase in viscosity raises the hydrostatic pressure in the sinusoids
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which in turn causes an excess of filtration/reabsorption flow thereby rapidly flushing out the
original interstitial fluid. This makes the presented modeling approach not only useful for the
particular case of portal HS injection but also for assessing the distribution of other hypertonic
solutions such as high concentration contrasts [49, 50].
According to the employed methodology, the physiological conductivity for blood would be
0.85 S/m, which is larger than the value commonly reported (about 0.65 S/m) [51] but close to
the reported value in other experimental studies (0.76 S/m) [52]. Physiological values for liver
conductivity at low frequency found in literature range widely from very low values (0.03 S/m)
[53] to larger values (0.126 S/m) [54]. The physiological conductivity predicted by the model is
0.09 S/m, which is close to the commonly reported value (0.075 S/m) [43] and within the range of
the basal conductivities, 0.11 ± 0.02 S/m (mean ± SD), obtained during the in vivo experiments
reported here.
In agreement with the results of the experimental study, the developed model is able to predict
the maximum conductivity with a 14.6% average relative error once HS is portally injected. These
results, together with the consistency of the basal conductivity results reported in the literature
(previous paragraph), indicate the goodness of the model for our purposes. However, we deem the
model could be further improved. In particular, we consider that a severe limitation of the model
is that it assumes constant macroscopic volumes. In contrast, it is known that the liver acts as
an expandable blood reservoir [55] and its compliance could hence play an important role. This
factor should be incorporated in future models in order to predict the expected conductivity even in
pathological states such as cirrhotic or fibrotic in which mechanical properties of the tissue differs
from the normal ones.
5. CONCLUSIONS
A mathematical model able to assess the resulting electrical conductivity of the liver when
hypertonic saline solution is portally injected is presented. The model is able to estimate the time-
space distribution of the solute within the different physiological compartments of the organ.
The results show that the developed model is able to predict with an average error of 14.6%
the maximum liver conductivity observed during the pilot in vivo study. The experiments were
conducted on pigs where liver electrical conductivity was measured during injection of NaCl at
20% through the portal vein at different volumes and flow rates. The goodness of the model would
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make it useful not only for the particular case of hypersaline injection but also for other non-isotonic
solutions injections such as high concentration contrasts.
Both mathematical modelization and pilot in vivo results show the feasibility of increasing up to
four times the conductivity of the healthy liver. These results encourage further development of the
multi-nodule ablation technique based on electroporation we have proposed.
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APPENDIX
Estimation of physiological parameters
Most of the parameters employed in the model (Table I) were extracted directly from the literature.
However, some of the required parameters could not be found in past experimental studies and had
to be estimated under some assumptions. In here it is described the processes for obtaining those
estimations.
First, the model requires the physiological volume of blood in each vascular tree (i.e. portal,
arterial and venous vasculature). Dimensional measurements of the intrahepatic vasculature were
reported in [56] by using casting resin. Based on these data - simplifying vessels as tubes - the total
volume of each tree was calculated (81.6 ml for the arterial tree, 236.7 ml for the portal tree and
288.0 ml for the venous tree). According to the liver weight employed in the experimental study
(1.9 kg) and the liver density (1070 kg/m3 [40]) the vasculature volume ratios with respect to the
total liver volume were calculated: 4.6% for the arterial tree, 13.3% for portal tree and 16.2% for
the venous tree.
Second, no data was found regarding the contact surface (Sc,hp) between the hepatocytes and
the interstitial space. Considering the sinusoids as tubes of radius rs (5 µm [37]), it was possible
to calculate the total length of the sinusoids per unit of liver volume (8.89×108 m/m3) required to
hold the sinusoidal blood (10.6% of parenchyma volume (VP ) [39]). The interstitial space was
then modeled as an annular region around the sinusoids with their same length. The width of
this region (1.05 µm) was determined by the physiological interstitial volume (Vp,hp) (4.9% of
parenchyma volume [39]). Finally, the interface between the hepatocytes and the interstitium per
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unit of liver volume was assumed to be the outer surface of the cylinder formed by the sinusoids and
the surrounding interstitial ring resulting in 337.9 cm2/ml.
Nomenclature
The mathematical model described in this work uses several parameters for its definition. The
employed nomenclature for this parameters follows the same structure. The main symbol (Table
A1) indicates the defined magnitude for the parameter, whereas the subscript or subscripts (Table
A2) indicate the anatomical location or state which is intended to be represented. Table A3 lists the
individual description for each of the parameters employed in the model.
Table A1. Description of magnitudes used in the model
Symbol Description
C Concentration of solute
h hematocrite
Kf Capillary filtration coefficient

























Table A3. Description of parameters used in the model
Symbol Description
Cc,ha Concentration in rbc at hepatic artery
Cc,hp Concentration in hepatocites at hepatocellular plate
Cc,pv Concentration in rbc at portal vein
Cc,s Concentration in rbc at sinusoids
Cc Concentration of solute at the cells
Chs Concentration of Hipertonic solution
Cp,ha Concentration of plasma at hepatic artery
Cp,hp Concentration of plasma at hepatocellular plate
Cp,pv Concentration of plasma at portal vein
Cp,s Concentration of plasma at sinusoids
Cp Concentration of solute in plasma
Cphys Physiological concentration
hha Hematocrite value at hepatic artery
hphys Hematocrite value at physiological state
hpv Hematocrite value at portal vein
hs Hematocrite value at sinusoids
Lc,ha Membrane hydraulic conductivity at hepatic artery
Lc,hp Membrane hydraulic conductivity at hepatocellular plates
Lc,pv Membrane hydraulic conductivity at portal vein
Lc,s Membrane hydraulic conductivity at sinusoids
Phv,phys Hydrostatic pressure at the beginning of the hepatic vein at physiological state
Phv Hydrostatic pressure at the beginning of the hepatic vein
Pi Hydrostatic pressure at the interstitial space
Ps,phys Hydrostatic pressure at the beginning of the sinusoids at physiological state
Ps Hydrostatic pressure at the beginning of the sinusoids
Qc,ha Flow of water leaving from cells at hepatic artery
Qc,hp Flow of water leaving from cells at hepatocellular plate
Qc,pv Flow of water leaving from cells at portal vein
Qc,s Flow of water leaving from cells at sinusoids
Qf Flow of filtration from sinusoids to interstitium
Qhs Flow of Hipertonic solution
Qhv Flow of blood at the hepatic vein
Qpv Flow of portal vein
Qr Flow of reabsortion from interstitium to sinusoids
Qs,phys Flow of blood through sinusoids at physiological state
Qs Flow of blood through sinusoids
Rs,phys Flow resistance of sinusoids at physiological state
Sc,ha Cellular membrane surface at hepatic artery
Sc,hp Cellular membrane surfac at hepatocellular plates
Sc,pv Cellular membrane surfac at portal vein
Sc,s Cellular membrane surfac at sinusoids
Vc,ha Volume of RBC at hepatic artery
Vc,hp Volume of hepatocytes at hepatocellular plate
Vc,pv Volume of RBC at portal vein
Vc,s Volume of RBC at sinusoids
Vp,ha Volume of plasma at hepatic artery
Vp,hp Volume of plasma at hepatocellular plate
Vp,pv Volume of plasma at portal vein
Vp,s Volume of plasma at sinusoids
VP Volume of the parenchyma
Vs Volume of the sinusoids
µphys Blood viscosity at physiological state
µs Blood viscosity at sinusoids
σeff Effective electrical conductivity
σL Electrical conductivity of liver
σp,hp Electrical conductivity of plasma at hepatocellular plates (interstitial liquid)
σp,s Electrical conductivity of sinusoidal plasma
σsi Electrical conductivity of sinusoids and interstitium liquid
σsolv Conductivity of the solvent
σp Electrical conductivity of plasma
σs Electrical conductivity of sinusoidal blood
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17. Schwen LO, Schenk A, Kreutz C, Timmer J, Bartolomé Rodrı́guez MM, Kuepfer L, Preusser T. Representative
Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations. Plos One 2015; 10(7):e0133 653, doi:10.1371/
20
journal.pone.0133653.
18. Lu J, Goldsmith MR, Grulke CM, Chang DT, Brooks RD, Leonard JA, Phillips MB, Hypes ED, Fair MJ,
Tornero-Velez R, et al.. Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support
of Provisional Model Construction. PLoS Computational Biology 2016; 12(2):1–22, doi:10.1371/journal.pcbi.
1004495.
19. Bickell WH, Bruttig SP, Millnamow GA, O’Benar J, Wade CE. Use of hypertonic saline/dextran versus lactated
ringer’s solution as a resuscitation fluid after uncontrolled aortic hemorrhage in anesthetized swine. Annals of
Emergency Medicine 1992; 21(9):1077–1085, doi:10.1016/S0196-0644(05)80648-1.
20. Mazzoni MC, Borgström P, Arfors KE, Intaglietta M. Dynamic fluid redistribution in hyperosmotic resuscitation of
hypovolemic hemorrhage. The American journal of physiology sep 1988; 255(3 Pt 2):H629–37.
21. Fosters K, Schwan H. Dielectric properties of tissues. Handbook of Biological Effects of Electromagnetic Fields,
Polk C, Postow E (eds.). chap. 1, CRC press, 1996; 25–102.
22. Huang WH, Chui CK, Teoh SH, Chang SKY. A multiscale model for bioimpedance dispersion of liver tissue. IEEE
Transactions on Biomedical Engineering 2012; 59(6):1593–1597, doi:10.1109/TBME.2012.2190511.
23. Trautman ED, Newbower RS. A practical analysis of the electrical conductivity of blood. IEEE Transactions on
Biomedical Engineeringmedical engineering mar 1983; 30(3):141–54.
24. Solazzo Sa, Liu Z, Lobo SM, Ahmed M, Hines-Peralta AU, Lenkinski RE, Goldberg SN. Radiofrequency ablation:
importance of background tissue electrical conductivity–an agar phantom and computer modeling study. Radiology
2005; 236:495–502, doi:10.1148/radiol.2362040965.
25. Grimnes S, Martinsen ØG, Martinsen O. Bioimpedance and Bioelectricity Basics. Academic Press: San Diego,
2000.
26. Peters MJ, Stinstra JG, Leveles I, He B. The Electrical Conductivity of Living Tissue: A Parameter in the
Bioelectrical Inverse Problem. Modeling and Imaging of Bioelectrical Activity 2005; c(1967):281–319, doi:
10.1007/978-0-387-49963-5 9.
27. Archie G. The Electrical Resistivity Log as an Aid in Determining Some Reservoir Characteristics. Petroleum
Technology 1942; (October):54–62, doi:10.2118/942054-G.
28. Glover PWJ. A generalized Archie’s law for n phases. Geophysics 2010; 75(6):E247, doi:10.1190/1.3509781.
29. Wambaugh J, Shah I. Simulating Microdosimetry in a Virtual Hepatic Lobule. PLoS Computational Biology 2010;
6(4):e1000 756, doi:10.1371/journal.pcbi.1000756.
30. Schwen LO, Krauss M, Niederalt C, Gremse F, Kiessling F, Schenk A, Preusser T, Kuepfer L. Spatio-temporal
simulation of first pass drug perfusion in the liver. PLoS computational biology mar 2014; 10(3):e1003 499, doi:
10.1371/journal.pcbi.1003499.
31. Greenway CV, Stark RD, Lautt WW. Capacitance Responses and Fluid Exchange in the Cat Liver during
Stimulation of the Hepatic Nerves. Circulation Research 1969; 25(3):277–284, doi:10.1161/01.RES.25.3.277.
32. Garcia-Canadilla P, Rudenick Pa, Crispi F, Cruz-Lemini M, Palau G, Camara O, Gratacos E, Bijens BH. A
Computational Model of the Fetal Circulation to Quantify Blood Redistribution in Intrauterine Growth Restriction.
PLoS Computational Biology 2014; 10(6):9–11, doi:10.1371/journal.pcbi.1003667.
33. Eliakim M, Rosenberg SZ, Braun K. Effect of Hypertonic Saline on the Pulmonary and Systemic Pressures.
Circulation Research may 1958; 6(3):357–362, doi:10.1161/01.RES.6.3.357.
34. Semler HJ, Shepherd JT, Swan HJ. Pressor effect of hypertonic saline on pulmonary circulation. Circulation
research 1959; 7(November 1959):1011–1017, doi:10.1161/01.RES.7.6.1011.
35. Schmid-Schönbein H, Wells R, Goldstone J. Influence of Deformability of Human Red Cells upon Blood Viscosity.
Circulation Research aug 1969; 25(2):131–143, doi:10.1161/01.RES.25.2.131.
21
36. Keiding S, Johansen S, Winkler K, Tonnesen K, Tygstrup N. Michaelis-Menten kinetics of galactose elimination
by the isolated perfused pig liver. The American journal of physiology 1976; 230(5):1302–1313.
37. Siggers JH, Leungchavaphongse K, Ho CH, Repetto R. Mathematical model of blood and interstitial flow and
lymph production in the liver. Biomechanics and Modeling in Mechanobiology apr 2014; 13(2):363–378, doi:
10.1007/s10237-013-0516-x.
38. Pries AR, Neuhaus D, Gaehtgens P. Blood viscosity in tube flow: dependence on diameter and hematocrit. The
American journal of physiology 1992; 263(6 Pt 2):H1770–H1778.
39. Blouin A, Bolender RP, Weibel ER. Distribution of organelles and membranes between hepatocytes and
nonhepatocytes in the rat liver parenchyma. A stereological study. The Journal of cell biology feb 1977; 72(2):441–
55.
40. Niehues SM, Unger JK, Malinowski M, Neymeyer J, Hamm B, Stockmann M. Liver volume measurement: reason
of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it.
European journal of medical research 2010; 15:345–350, doi:10.1186/2047-783X-15-8-345.
41. Muirhead E, Lackey RW, Hill JM, Bunde A. Transient hypotension following rapid intravenous injections of
hypertonic solutions. Am J Physiol. 1947; 151(2):516–524.
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